Found: 7
Select item for more details and to access through your institution.
Macrophage inclusions in cerebrospinal fluid following treatment initiation with antisense oligonucleotide therapies in motor neuron diseases.
- Published in:
- Neurological Research & Practice, 2024, v. 6, n. 1, p. 1, doi. 10.1186/s42466-023-00305-0
- By:
- Publication type:
- Article
Current State and Future Directions in the Diagnosis of Amyotrophic Lateral Sclerosis.
- Published in:
- Cells (2073-4409), 2023, v. 12, n. 5, p. 736, doi. 10.3390/cells12050736
- By:
- Publication type:
- Article
Correction: Cognitive performance of adult patients with SMA before and after treatment initiation with nusinersen.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Cognitive performance of adult patients with SMA before and after treatment initiation with nusinersen.
- Published in:
- BMC Neurology, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12883-023-03261-z
- By:
- Publication type:
- Article
Cognitive performance of adult patients with SMA before and after treatment initiation with nusinersen.
- Published in:
- BMC Neurology, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12883-023-03261-z
- By:
- Publication type:
- Article
Cognitive performance of adult patients with SMA before and after treatment initiation with nusinersen.
- Published in:
- BMC Neurology, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12883-023-03261-z
- By:
- Publication type:
- Article
Neurofilament light‐chain response during therapy with antisense oligonucleotide tofersen in SOD1‐related ALS: Treatment experience in clinical practice.
- Published in:
- Muscle & Nerve, 2023, v. 67, n. 6, p. 515, doi. 10.1002/mus.27818
- By:
- Publication type:
- Article